The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models
D'Amato, V, Rosa, R, D'Amato, C, Formisano, L, Marciano, R, Nappi, L, Raimondo, L, Di Mauro, C, Servetto, A, Fusciello, C, Veneziani, B M, De Placido, S, Bianco, RVolume:
110
Langue:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2014.241
Date:
June, 2014
Fichier:
PDF, 1009 KB
english, 2014
File converter
Plus de résultats de recherche
More benefits 
